Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders

Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders

US Patent 9475856 · Granted Oct 25, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble alpha-Klotho proteins, protein fragments, and uses thereof2025
Chimeric fibroblast growth factor 21 proteins and methods of use2020
Chimeric fibroblast growth factor 21 proteins and methods of use2020
Chimeric fibroblast growth factor 19 proteins and methods of use2020
Chimeric fibroblast growth factor 19 proteins and methods of use2020
FGF23 c-tail fusion proteins2019
FGF23 c-tail fusion proteins2019
Chimeric fibroblast growth factor 23 proteins and methods of use2019
Chimeric fibroblast growth factor 23 proteins and methods of use2019
FGF21 protein with enhanced binding affinity for β-Klotho for the treatment of t2019
FGF21 protein with enhanced binding affinity for β-Klotho for the treatment of t2019
Chimeric fibroblast growth factor 21 proteins and methods of use2018